Ultragenyx Pharmaceutical | RARE - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Agios Pharmaceuticals USD 58.84M 23.36M 2026-03
Alnylam Pharmaceuticals USD 1.35B 116.87M 2026-03
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Esperion Therapeutics USD 300.36M 451K 2026-03
Immunic USD 38.36M 7.74M 2026-03
Insmed USD 361.01M 107.87M 2026-03
Ionis Pharmaceuticals USD 717M 66M 2026-03
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Kyowa Hakko Kirin JPY 144.64B 36.43B 2026-03
MacroGenics USD 95.94M 52.82M 2026-03
Moderna USD 2.4B 408M 2026-03
Neurocrine Biosciences USD 831.7M 88.3M 2026-03
PTC Therapeutics USD 923.6M 44.82M 2026-03
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Sarepta Therapeutics USD 499.16M 596.13M 2026-03
Ultragenyx Pharmaceutical USD 325M 59M 2026-03
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03
Xoma USD 28.3M 6.81M 2025-09